Enterprise Financial Services Corp (EFSC)’s Takeda Pharmaceutical TAK Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,178	Closed	-$20K	–	1119
2021 Q2	$20K	Buy	1,178 +168	+17%	+$2.86K	﹤0.01%	588
2021 Q1	$19K	Buy	1,010 +176	+21%	+$3.17K	﹤0.01%	606
2020 Q4	$15K	Sell	834 -58	-7%	-$1.02K	﹤0.01%	630
2020 Q3	$16K	Sell	892 -29	-3%	-$528	﹤0.01%	602
2020 Q2	$17K	Buy	921 +512	+125%	+$9.19K	﹤0.01%	584
2020 Q1	$6K	Sell	409 -538	-57%	-$9.75K	﹤0.01%	773
2019 Q4	$18K	Buy	947 +430	+83%	+$8.23K	﹤0.01%	603
2019 Q3	$9K	Buy	517 +202	+64%	+$3.49K	﹤0.01%	733
2019 Q2	$5K	Sell	315 -245	-44%	-$4.46K	﹤0.01%	903
2019 Q1	$11K	Buy	560 +550	+5,500%	+$11.1K	﹤0.01%	732
2018 Q4	$0	Buy	+10	New	+$169	﹤0.01%	1061

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s TAK Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 1,178 shares — an estimated $20K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in TAK in Q4 2018 and held it in 11 quarters. The position peaked at $20K in Q2 2021. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

Enterprise Financial Services Corp (EFSC) reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 1,178 Takeda Pharmaceutical shares in Q3 2021, an estimated $20K.
Enterprise Financial Services Corp (EFSC) first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 11 quarters.
Enterprise Financial Services Corp (EFSC)'s Takeda Pharmaceutical position peaked at $20K in Q2 2021.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.